ArticleCureus2026
Percutaneous Transcatheter Closure of Multiple Ostium Secundum Atrial Septal Defects: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ostium secundum atrial septal defects (ASDs) are a common congenital heart defect that are often asymptomatic until adulthood. Percutaneous transcatheter device closure is now a widely accepted form of treatment as an alternative to surgical repair. A 61-year-old woman presented with two secundum ASDs measuring 17 mm (superior) and 14 mm (inferior) with evidence of significant left-to-right shunting along with right ventricular and right atrial enlargement. Under the guidance of transesophageal echocardiography (TEE), the inferior defect was closed first with an 11 mm Amplatzer septal occluder (ASO) (Abbott Medical Inc., IL, USA), and the superior defect was closed next with an 18 mm ASO. The devices were interdigitated and deployed in a staged fashion to avoid entanglement. Immediate TEE and color Doppler confirmed that both devices were well seated across all rims with no residual shunt. In this case, a two-device strategy using ASOs was required due to the defects being spatially distant from one another. Careful preparation through balloon sizing, TEE guidance, and sequential deployment was taken to minimize the risk of device embolization. This case demonstrates that percutaneous transcatheter device closure through multiple devices is a feasible alternative to a surgical patch in patients with multiple ostium secundum ASDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.